“Triple-Punch” Strategy Exosome-Mimetic Nanovesicles for Triple Negative Breast Cancer Therapy
Author:
Affiliation:
1. School of Medicine, State Key Laboratory of Medicinal Chemical Biology, Nankai University, 94 Weijin Road, Tianjin 300071, China
Funder
Natural Science Foundation of Tianjin-Science and Technology Correspondent Project
Publisher
American Chemical Society (ACS)
Link
https://pubs.acs.org/doi/pdf/10.1021/acsnano.3c10568
Reference53 articles.
1. Progress and challenges of immunotherapy in triple-negative breast cancer
2. Recent advances in targeted strategies for triple-negative breast cancer
3. Triple‑negative breast cancer therapy: Current and future perspectives (Review)
4. Treatment landscape of triple-negative breast cancer — expanded options, evolving needs
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Non-viral gene therapy for neuromuscular diseases including Duchenne muscular dystrophy using nanovesicles derived from human cells;Rare Disease and Orphan Drugs Journal;2024-09-02
2. Three-Dimensional Visualization of Breast Cancer Pathology Evolution in Clinical Patient Tissues with NIR-II Imaging;Nano Letters;2024-08-09
3. Recent Progress of Multifunctional Molecular Probes for Triple-Negative Breast Cancer Theranostics;Pharmaceutics;2024-06-14
4. Role of Exosomes in Cancer and Aptamer-Modified Exosomes as a Promising Platform for Cancer Targeted Therapy;Biological Procedures Online;2024-05-27
5. G4-Hemin-loaded 2D nanosheets for combined and targeted chemo-photodynamic cancer therapy;Nanoscale;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3